Can a 12-Week lifestyle program slash heart risk in families?

NCT ID NCT00552591

Completed Prevention Sponsor: Ottawa Heart Institute Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests whether a 12-week program led by a heart health educator can lower cholesterol and improve heart health in spouses, siblings, and children of people hospitalized with coronary heart disease. Participants work with an educator to create a personal plan for smoking cessation, exercise, healthy eating, and weight management, with medication support if needed. The goal is to see if this targeted approach reduces the ratio of total to HDL cholesterol and other risk factors compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 12-week risk reduction program with heart health educator
What this could lead to: If effective, this program could offer a simple, low-cost way to help families of heart patients lower their own heart disease risk through lifestyle changes and medication support.
What could go wrong: This is a single-center trial with 426 participants, so results may not apply to all populations. The program relies on personal motivation, and long-term adherence is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY HEART DISEASE

Contacts and locations

Locations

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.